Safety and tolerability profile of second-line anti-tuberculosis medications.
about
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic ModelComplexation of clofazimine by macrocyclic cucurbit[7]uril reduced its cardiotoxicity without affecting the antimycobacterial efficacy.Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012-2014Reynosin and santamarine: two sesquiterpene lactones from Ambrosia confertiflora with bactericidal activity against clinical strains of Mycobacterium tuberculosis.Inhaled Pyrazinoic Acid Esters for the Treatment of Tuberculosis.Tuberculous Meningitis in Children and Adults: New Insights for an Ancient Foe.The Pharmacokinetics of 2000 mg Ertapenem in Tuberculosis Patients.
P2860
Q30379233-5EBB084B-5C46-4E60-A6A5-3AE5DD59A920Q31116166-FA8A2263-DCEA-40C1-90C4-E3B344683C0CQ36617035-530FCB45-17C0-495B-9B19-C81495EF38FFQ38770792-0C970C6A-5F2D-4F67-A470-7F6D708D64B4Q40634015-1F83D59D-F63E-4888-A6DE-49CE1310C0CDQ47192301-AD05363D-F08E-4821-A6C6-6B769CFBEA66Q50028072-DE824E1D-B877-4A18-9266-09FE1715F7EE
P2860
Safety and tolerability profile of second-line anti-tuberculosis medications.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Safety and tolerability profile of second-line anti-tuberculosis medications.
@en
type
label
Safety and tolerability profile of second-line anti-tuberculosis medications.
@en
prefLabel
Safety and tolerability profile of second-line anti-tuberculosis medications.
@en
P2860
P1433
P1476
Safety and tolerability profile of second-line anti-tuberculosis medications.
@en
P2093
Geetha Ramachandran
P2860
P2888
P304
P356
10.1007/S40264-015-0267-Y
P577
2015-03-01T00:00:00Z
P5875
P6179
1013277223